Mirtazapine
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Prescription noradrenergic and specific serotonergic antidepressant (NaSSA) approved for major depressive disorder. Known for its sedating and appetite-stimulating properties, which can be therapeutically useful in patients with insomnia and poor appetite or weight loss. At lower doses, sedation is more prominent due to stronger histamine H1 blockade; at higher doses, noradrenergic activation can offset sedation. Dosage must be determined by your prescribing physician.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Prescription noradrenergic and specific serotonergic antidepressant (NaSSA) approved for major depressive disorder. NutriStack rates the supporting evidence as strong. Common adult dosing is 15–45 mg daily at bedtime (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete sodium. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: depression symptom relief, sleep improvement, appetite stimulation. 10 sources indexed (2015–2026), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Antagonizes central presynaptic alpha-2 adrenergic receptors, enhancing norepinephrine and serotonin release. Also blocks serotonin 5-HT2A, 5-HT2C, and 5-HT3 receptors, directing serotonin activity toward 5-HT1A receptors. Potent histamine H1 receptor antagonist (contributing to sedation and weight gain) with minimal anticholinergic activity.
Dosing & protocol.
Can be taken with or without food. Typically administered at bedtime due to sedating effects. Orally disintegrating tablets dissolve on the tongue without water.3
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Sodium
ModerateAntidepressant-associated SIADH can increase renal free-water retention and dilute serum sodium, producing hyponatremia.
Full safety detail.
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
6- 1Mirtazapine in pregnancy and lactation: A systematic review of adverse outcomesPMIDOstenfeld A, Lyngholm S, Christensen SE et al. · Acta psychiatrica Scandinavica · 2025
Ostenfeld A, Lyngholm S, Christensen SE et al.. Mirtazapine in pregnancy and lactation: A systematic review of adverse outcomes. Acta psychiatrica Scandinavica. 2025
- 2Mirtazapine-induced Acute Pancreatitis in Patients With Depression: A Systematic ReviewPMIDMilosavljević MN, Janković SM, Kostić MJ et al. · Journal of psychiatric practice · 2023
Milosavljević MN, Janković SM, Kostić MJ et al.. Mirtazapine-induced Acute Pancreatitis in Patients With Depression: A Systematic Review. Journal of psychiatric practice. 2023
- 3Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysisPMIDFurukawa TA, Cipriani A, Cowen PJ et al. · The lancet. Psychiatry · 2019
Furukawa TA, Cipriani A, Cowen PJ et al.. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. The lancet. Psychiatry. 2019
- 4The role of mirtazapine in patients with fibromyalgia: a systematic reviewPMIDOttman AA, Warner CB, Brown JN · Rheumatology international · 2018
Ottman AA, Warner CB, Brown JN. The role of mirtazapine in patients with fibromyalgia: a systematic review. Rheumatology international. 2018
- 5Mirtazapine in pregnancy and lactation - A systematic reviewPMIDSmit M, Dolman KM, Honig A · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2016
Smit M, Dolman KM, Honig A. Mirtazapine in pregnancy and lactation - A systematic review. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2016
- 6Meta-Analysis of Efficacy of Mirtazapine as an Adjunctive Treatment of Negative Symptoms in SchizophreniaPMIDVidal C, Reese C, Fischer BA et al. · Clinical schizophrenia & related psychoses · 2015
Vidal C, Reese C, Fischer BA et al.. Meta-Analysis of Efficacy of Mirtazapine as an Adjunctive Treatment of Negative Symptoms in Schizophrenia. Clinical schizophrenia & related psychoses. 2015
Randomized controlled trials
1- 7Mirtazapine or ondansetron for hyperemesis gravidarum: a randomized placebo-controlled trialPMIDOstenfeld A, Carlsen SE, Jensen AK et al. · American journal of obstetrics and gynecology · 2026
Ostenfeld A, Carlsen SE, Jensen AK et al.. Mirtazapine or ondansetron for hyperemesis gravidarum: a randomized placebo-controlled trial. American journal of obstetrics and gynecology. 2026
Reference material
3- 8Cipriani A et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018.Source linkedPMID
- 9Watanabe N et al. Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2011.Source linkedPMID
- 10Quiles C Treating the Pain After the Cure: Therapeutic Approaches for Post-ECT Headache-A Systematic Review. J ECT. 2026.Source linkedPMID
Common questions.
Quick answers about Mirtazapine, drawn from the data on this page.
What is Mirtazapine?
Prescription noradrenergic and specific serotonergic antidepressant (NaSSA) approved for major depressive disorder. Known for its sedating and appetite-stimulating properties, which can be therapeutically useful in patients with insomnia and poor appetite or weight loss. At lower doses, sedation is more prominent due to stronger histamine H1 blockade; at higher doses, noradrenergic activation can offset sedation. Dosage must be determined by your prescribing physician.
What is Mirtazapine used for?
Commonly cited benefits of Mirtazapine include: Depression symptom relief; Sleep improvement; Appetite stimulation; Low incidence of sexual side effects; Nausea reduction. NutriStack rates the overall evidence as strong.
What is a typical dose of Mirtazapine?
A typical adult dose of Mirtazapine is 15–45 mg daily at bedtime (as prescribed by your physician). The commonly recommended form is Tablet or orally disintegrating tablet. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Mirtazapine?
Reported side effects include sedation and drowsiness, weight gain, increased appetite, dry mouth, constipation, dizziness. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Mirtazapine?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Mirtazapine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.